Healthcare provider profile · identity verified

Thomas W. Rossiter, MD

Internal Medicine · SPRINGFIELD, MO · NPI 1720143118

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1068	310
Amlodipine Besylate	Amlodipine Besylate	870	253
Levothyroxine Sodium	Levothyroxine Sodium	744	213
Losartan Potassium	Losartan Potassium	623	172
Lisinopril	Lisinopril	593	174
Pantoprazole Sodium	Pantoprazole Sodium	500	145
Metoprolol Succinate	Metoprolol Succinate	495	132
Omeprazole	Omeprazole	426	131
Hydrochlorothiazide	Hydrochlorothiazide	363	101
Sertraline Hcl	Sertraline Hcl	355	107
Alprazolam	Alprazolam	321	68
Tamsulosin Hcl	Tamsulosin Hcl	318	92
Eliquis	Apixaban	314	64
Furosemide	Furosemide	293	78
Trazodone Hcl	Trazodone Hcl	279	77
Pravastatin Sodium	Pravastatin Sodium	273	82
Potassium Chloride	Potassium Chloride	271	76
Gabapentin	Gabapentin	251	78
Simvastatin	Simvastatin	242	69
Metoprolol Tartrate	Metoprolol Tartrate	237	71
Metformin Hcl	Metformin Hcl	236	70
Finasteride	Finasteride	227	59
Warfarin Sodium	Warfarin Sodium	220	26
Fluticasone Propionate	Fluticasone Propionate	217	77
Rosuvastatin Calcium	Rosuvastatin Calcium	215	62
Meloxicam	Meloxicam	212	55
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	205	57
Metformin Hcl Er	Metformin Hcl	193	59
Bupropion Xl	Bupropion Hcl	174	44
Tramadol Hcl	Tramadol Hcl	171	51
Carvedilol	Carvedilol	157	45
Allopurinol	Allopurinol	149	41
Citalopram Hbr	Citalopram Hydrobromide	149	43
Albuterol Sulfate Hfa	Albuterol Sulfate	128	43
Escitalopram Oxalate	Escitalopram Oxalate	121	37
Montelukast Sodium	Montelukast Sodium	115	34
Mirtazapine	Mirtazapine	112	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	111	51
Glipizide	Glipizide	107	31
Clopidogrel	Clopidogrel Bisulfate	97	33
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	96	29
Arexvy	Rsvpref3 Antigen/As01e/Pf	93	93
Duloxetine Hcl	Duloxetine Hcl	92	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	91	25
Isosorbide Mononitrate Er	Isosorbide Mononitrate	87	25
Spironolactone	Spironolactone	87	24
Famotidine	Famotidine	85	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	84	29
Zolpidem Tartrate	Zolpidem Tartrate	84	21
Clonazepam	Clonazepam	83	14
Alendronate Sodium	Alendronate Sodium	82	28
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	82	21
Irbesartan	Irbesartan	82	24
Glimepiride	Glimepiride	77	22
Glipizide Er	Glipizide	77	24
Lovastatin	Lovastatin	73	21
Ezetimibe	Ezetimibe	68	19
Jardiance	Empagliflozin	68	15
Buspirone Hcl	Buspirone Hcl	65	19
Venlafaxine Hcl Er	Venlafaxine Hcl	63	14
Tizanidine Hcl	Tizanidine Hcl	61	29
Donepezil Hcl	Donepezil Hcl	58	18
Azelastine Hcl	Azelastine Hcl	57	23
Hydralazine Hcl	Hydralazine Hcl	57	12
Prednisone	Prednisone	56	25
Doxazosin Mesylate	Doxazosin Mesylate	55	17
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	52	43
Olmesartan Medoxomil	Olmesartan Medoxomil	50	11
Synthroid	Levothyroxine Sodium	48	16
Xarelto	Rivaroxaban	48	16
Paroxetine Hcl	Paroxetine Hcl	47	14
Atenolol	Atenolol	45	suppressed
Lorazepam	Lorazepam	45	17
Celecoxib	Celecoxib	43	16
Farxiga	Dapagliflozin Propanediol	42	11
Nitroglycerin	Nitroglycerin	42	33
Breo Ellipta	Fluticasone/Vilanterol	41	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	40	suppressed
Ipratropium Bromide	Ipratropium Bromide	38	13
Ozempic	Semaglutide	38	suppressed
Ropinirole Hcl	Ropinirole Hcl	38	13
Fluoxetine Hcl	Fluoxetine Hcl	37	13
Benazepril Hcl	Benazepril Hcl	35	suppressed
Ramipril	Ramipril	35	11
Bumetanide	Bumetanide	34	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	12
Memantine Hcl	Memantine Hcl	33	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	32	32
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	32	suppressed
Clonidine Hcl	Clonidine Hcl	31	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	31	suppressed
Terazosin Hcl	Terazosin Hcl	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	11
Klor-Con M20	Potassium Chloride	30	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	29	19
Triamcinolone Acetonide	Triamcinolone Acetonide	29	14
Estradiol	Estradiol	28	suppressed
Trulicity	Dulaglutide	28	suppressed
Myrbetriq	Mirabegron	27	suppressed
Promethazine Hcl	Promethazine Hcl	26	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Torsemide	Torsemide	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	17
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	14
Paxlovid	Nirmatrelvir/Ritonavir	21	21
Enalapril Maleate	Enalapril Maleate	20	suppressed
Incruse Ellipta	Umeclidinium Bromide	20	suppressed
Mounjaro	Tirzepatide	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	18	suppressed
Arnuity Ellipta	Fluticasone Furoate	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Dilt-Xr	Diltiazem Hcl	17	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Digoxin	Digoxin	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Methylprednisolone	Methylprednisolone	16	13
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	suppressed
Flecainide Acetate	Flecainide Acetate	15	suppressed
Lactulose	Lactulose	15	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Tresiba Flextouch U-200	Insulin Degludec	15	suppressed
Valsartan	Valsartan	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Azathioprine	Azathioprine	14	suppressed
Baclofen	Baclofen	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Colchicine	Colchicine	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Movantik	Naloxegol Oxalate	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Breyna	Budesonide/Formoterol Fumarate	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Cephalexin	Cephalexin	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Mometasone Furoate	Mometasone Furoate	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error